Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 7;32(8):1251-1266.e8.
doi: 10.1016/j.stem.2025.06.010. Epub 2025 Jul 17.

Non-canonical functions of DNMT3A in hematopoietic stem cells regulate telomerase activity and genome integrity

Affiliations

Non-canonical functions of DNMT3A in hematopoietic stem cells regulate telomerase activity and genome integrity

Infencia Xavier Raj et al. Cell Stem Cell. .

Abstract

DNMT3A is a critical regulator of hematopoietic stem cell (HSC) fate decisions and the most recurrently mutated gene in human clonal hematopoiesis (CH). DNMT3A is described as a DNA methyltransferase enzyme, but cells with DNMT3A loss of function show minor changes in DNA methylation that do not correlate with altered gene expression. To explore the possibility that Dnmt3a has DNA-methylation-independent functions in HSCs, we created an allelic series of mice with varying levels of DNA-methylation-impaired Dnmt3a. Clonal expansion of Dnmt3a-deficient HSCs was rescued by Dnmt3a proteins lacking DNA methylation capacity, suggesting that Dnmt3a has important non-canonical functions in HSCs. Dnmt3a-null HSCs can be transplanted indefinitely, implying the ability to circumvent mechanisms that limit the replicative lifespan of HSCs, such as telomere shortening. Dnmt3a-null HSCs show increased telomerase activity and sustain telomere length over serial transplantation, revealing a previously unidentified role for DNMT3A mutations in regulating HSC longevity that is unrelated to DNA methylation function.

Keywords: DNA methylation; DNMT3A; hematopoietic stem cell; telomerase; telomere.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare the following competing interests (unrelated to this work): T.M.P. has performed consulting for Pillar Patient Advocates, Silence Therapeutics, and the MPNRF. A.L.Y. has performed consulting for BioGenerator and is a co-founder, CEO, and shareholder of Pairidex, Inc. L.F.Z.B. has received research funding from Enanta Pharma. G.A.C. has performed consulting and received research funding from Incyte, Ajax Therapeutics, and ReNAgade Therapeutics Management, and is a co-founder, member of the scientific advisory board, and shareholder of Pairidex, Inc.

References

    1. Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS, Bock C, Vasanthakumar A, Gu H, Xi Y, et al. (2012). Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 44, 23–31. 10.1038/ng.1009. - DOI - PMC - PubMed
    1. Challen GA, Sun D, Mayle A, Jeong M, Luo M, Rodriguez B, Mallaney C, Celik H, Yang L, Xia Z, et al. (2014). Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell 15, 350–364. 10.1016/j.stem.2014.06.018. - DOI - PMC - PubMed
    1. Zhang CR, Ostrander EL, Kukhar O, Mallaney C, Sun J, Haussler E, Celik H, Koh WK, King KY, Gontarz P, and Challen GA (2022). Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21. Blood Cancer Discov, OF1–OF20. 10.1158/2643-3230.BCD-21-0132. - DOI - PMC - PubMed
    1. Hormaechea-Agulla D, Matatall KA, Le DT, Kain B, Long X, Kus P, Jaksik R, Challen GA, Kimmel M, and King KY (2021). Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNgamma signaling. Cell Stem Cell 28, 1428–1442 e1426. 10.1016/j.stem.2021.03.002. - DOI - PMC - PubMed
    1. Zhang CRC, Nix D, Gregory M, Ciorba MA, Ostrander EL, Newberry RD, Spencer DH, and Challen GA (2019). Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. Exp Hematol 80, 36–41 e33. 10.1016/j.exphem.2019.11.008. - DOI - PMC - PubMed

LinkOut - more resources